TB Research

Anti-tuberculosis therapy combined with ventriculoperitoneal shunt for tuberculous meningitis combined with hydrocephalus: A case report

Sheng C, Wang M, Bao Q, Guo W, Fu H, Li X, Zhang C, Xu K

Journal of infection and public health · 2025-07

Abstract

Tuberculous meningitis is a severe and potentially life-threatening form of central nervous system tuberculosis. Hydrocephalus is a critical complication and risk factor for the high mortality of tuberculous meningitis, exacerbating neurological damage and intensifying treatment. We reported a critical case of an elderly male patient with altered consciousness of consciousness who was diagnosed as tuberculous meningitis with hydrocephalus. The patient was treated with multi-drug anti-tuberculosis therapy, intracranial hypertension control, and surgical intervention consisting of external ventricular drainage and ventriculoperitoneal shunt, which successfully cured the patient.

MeSH terms

  • Humans
  • Tuberculosis, Meningeal
  • Hydrocephalus
  • Antitubercular Agents
  • Treatment Outcome
  • Drug Therapy, Combination
  • Ventriculoperitoneal Shunt
  • Aged
  • Male